首页> 中文期刊> 《中国卒中杂志》 >急性脑出血早期血肿扩大止血治疗研究进展

急性脑出血早期血肿扩大止血治疗研究进展

         

摘要

既往研究证实,脑出血后血肿扩大与早期神经功能恶化密切相关,往往预示着不良临床结局。血肿扩大是脑出血具有前景的治疗靶点。若不加筛选地对所有脑出血患者进行止血治疗,不但不能改善功能结局,反而可能增加动脉血栓栓塞不良事件风险。计算机断层扫描血管造影(computed tomography angiography,CTA)点样征是血肿扩大和不良预后安全有效的预测指标。应用点样征筛选血肿扩大高风险患者,并选用安全、经济的止血药物进行个体化止血治疗,对于遏制患者早期病情恶化及改善预后有重要意义。%Past studies have evidenced the strong relationship between hematoma enlargement after intracerebral hemorrhage (ICH) and early neurological deterioration, indicating poor clinical outcome. Hematoma enlargement is a potentially important therapeutic target. However, hemostatic therapy to all ICH patients indiscriminately does not improve functional outcome, but increases the incidence of arterial thromboembolic adverse events (TAE). Contrast extravasation on CT angiography, namely “spot sign”, predicts hematoma expansion and poor prognosis in acute intracerebral hemorrhage with safety and efficacy. It plays a central role in prevention of early deterioration and improvement of functional outcome to rely on the “spot sign” for the selection of patients to receive early hemostatic therapy with safe and economical hemostatic agents. This study summarizes the related research situation and trend, so as to provide reference for clinical practice.

著录项

相似文献

  • 中文文献
  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号